Published in Rev Diabet Stud on December 28, 2012
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care (2015) 1.36
Metabolomics applied to the pancreatic islet. Arch Biochem Biophys (2015) 0.78
Metabolomics in childhood diabetes. Pediatr Diabetes (2015) 0.76
Metabolomics allow the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Int J Obes (Lond) (2017) 0.75
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 25.57
Personal genomes: The case of the missing heritability. Nature (2008) 19.56
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
The control of flux. Symp Soc Exp Biol (1973) 12.14
HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet (2001) 7.79
Gut microbiota in health and disease. Physiol Rev (2010) 7.76
Human metabolic individuality in biomedical and pharmaceutical research. Nature (2011) 6.56
Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev (2005) 5.98
MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics (2010) 5.77
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science (2013) 5.75
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet (2008) 5.23
A genome-wide perspective of genetic variation in human metabolism. Nat Genet (2009) 5.00
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 4.88
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature (2011) 4.32
Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet (2012) 4.08
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest (2011) 3.23
Data processing for mass spectrometry-based metabolomics. J Chromatogr A (2007) 3.21
Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A (1971) 3.14
The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev (2004) 3.10
Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One (2010) 2.94
Environmental triggers and determinants of type 1 diabetes. Diabetes (2005) 2.93
Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr (2006) 2.83
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med (2008) 2.79
Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes (2009) 2.68
The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2009) 2.59
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst (2009) 2.49
Can a biologist fix a radio?--Or, what I learned while studying apoptosis. Cancer Cell (2002) 2.28
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One (2011) 2.18
XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem (2008) 2.10
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol (2011) 1.89
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab (2012) 1.55
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.37
Ten questions about systems biology. J Physiol (2011) 1.36
Metabolome in progression to Alzheimer's disease. Transl Psychiatry (2011) 1.33
Shotgun lipidomics by tandem mass spectrometry under data-dependent acquisition control. Methods Enzymol (2007) 1.32
Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol (2011) 1.28
Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Anal Chem (2011) 1.24
Probabilistic assignment of formulas to mass peaks in metabolomics experiments. Bioinformatics (2008) 1.22
Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia (2011) 1.20
Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics (2011) 1.19
Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes (2011) 1.14
Bioinformatics and computational methods for lipidomics. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.13
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res (2010) 1.10
Gender-dependent progression of systemic metabolic states in early childhood. Mol Syst Biol (2008) 1.08
Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol (2011) 1.06
Causes of early-onset type 1 diabetes: toward data-driven environmental approaches. J Exp Med (2008) 1.05
Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. J Atheroscler Thromb (2007) 1.03
Metabolomics platforms for genome wide association studies--linking the genome to the metabolome. Curr Opin Biotechnol (2012) 0.99
MPEA--metabolite pathway enrichment analysis. Bioinformatics (2011) 0.96
Onset of type 1 diabetes: a dynamical instability. Diabetes (1999) 0.94
Identification and MS-assisted interpretation of genetically influenced NMR signals in human plasma. Genome Med (2013) 0.88
Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res (2012) 0.86
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging. Cancer Metab (2013) 0.86
Beneficial autoimmunity in Type 1 diabetes mellitus. Trends Immunol (2005) 0.84
Altered metabolic signature in pre-diabetic NOD mice. PLoS One (2012) 0.83
Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine. J R Soc Interface (2012) 0.82
Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study). Metabolomics (2011) 0.80
Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications. Expert Rev Mol Diagn (2012) 0.80
Integrated model of metabolism and autoimmune response in β-cell death and progression to type 1 diabetes. PLoS One (2012) 0.78
Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn (2006) 1.41